Clinical Trial Update: Evaluation of Tocilizumab as an add-on Therapy to Corticoids in Giant Cell Arteritis: Proof of Concept Study. [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept trial evaluating tocilizumab as add-on therapy to corticosteroids in giant cell arteritis (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Giant Cell Arteritis | Phase 2 | Status: COMPLETED